Institution
Institut universitaire du cancer de Toulouse Oncopole
Also known as: University Cancer Institute Toulouse Oncopole · IUCT
- 126running trials
- 62closed trials
- 7,217publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Early detection of triple negative breast cancer relapse (CUPCAKE)
Recruiting
Recruiting
Recruiting
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Recruiting
Active, not recruiting
Recruiting
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 126.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
- Childhood cancers7 recruiting
- Multiple myeloma6 recruiting
- Triple-negative breast cancer6 recruiting
- Metastatic breast cancer5 recruiting
- Prostate cancer5 recruiting
- Sarcoma5 recruiting
- Acute myeloid leukaemia4 recruiting
- Ovarian cancer4 recruiting
- Bladder cancer3 recruiting
- Cervical cancer3 recruiting
- Colorectal cancer3 recruiting
- Endometrial cancer3 recruiting
- Head and neck cancer3 recruiting
- Kidney cancer3 recruiting
- Pancreatic cancer3 recruiting
- Gastric and oesophageal cancer2 recruiting
- Glioblastoma2 recruiting
- Melanoma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Amyloidosis1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
Completed
Completed
Completed
Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Completed
Completed
Completed
Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Completed
Terminated
Completed
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
Completed
Completed
Completed
Completed
Completed
Completed
Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Active, not recruiting
Completed
An efficacy and safety study of 2-OHOA in patients with glioblastoma
Completed
Completed
Completed
SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
Completed
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Completed
Completed
Completed
Showing 50 of 62.
Registry name variants (14)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Institut Universitaire Du Cancer Toulouse-Oncopole
Toulouse Cedex 9, 31059
109 trials
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, 31059
60 trials
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, 31059
17 trials
Institut Universitaire Du Cancer Toulouse - Oncopole (Iuct-O)
Toulouse
2 trials
Contact: Pierre VANDE PERRE
Contact: Agnès DUPRET-BORIES
Institut Universitaire de Cancer de Toulouse Oncopole
Toulouse, 31100
1 trial
Institut universitaire du cancer de Toulouse - Oncopole, Institut Claudius Regaud
Toulouse, 31059
1 trial
NCT02838602Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
Contact: Anne DUCASSOU, MD
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole)
Toulouse, 31100
1 trial
University Institute Cancer Toulouse Oncopole
Toulouse, 31059
1 trial
Institut Univ du Cancer de Toulouse-Oncopole
Toulouse
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O) - Institut Claudius Regaud
Toulouse, 31059
Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)
Toulouse, 31059
Institut Universitaire du Cancer Toulouse - Oncopole (Site 0455)
Toulouse, Haute-Garonne 31059
Institut Universitaire du Cancer Toulouse - Oncopole (Site 2065)
Toulouse, Haute-Garonne 31059
Oncopole, Institute Universitaire du Cancer de Toulouse (IUCT Toulouse)
Toulouse
Conditions
Diseases this institution publishes on or runs trials for.
- Multiple myeloma48 works · 24 trials
- Ovarian cancer36 works · 11 trials
- Acute myeloid leukaemia28 works · 13 trials
- Metastatic breast cancer17 works · 18 trials
- Hodgkin lymphoma12 works · 4 trials
- Myelodysplastic syndromes11 works · 7 trials
- Follicular lymphoma10 works · 6 trials
- Aplastic anaemia4 works · 0 trials
Institution data: ROR 014hxhm89 (CC0-1.0)Updated 15 Nov 2026